Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy
95% CI, 0.510.60
Any future prescribing guidance would define specific eligibility criteria
US$ 26.72
US$ 26.69
US$ 21.74
US$ 28.57
US$ 4580.00
Sold : Login>>
